125031

Recent supplemental applications (e.g., BLA 125031/S-0202) have added critical safety information to the drug's labeling, including increased risks of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) when used alongside chemotherapy or radiation for breast and lung cancer. Scientific Literature Identifier

Is there a —such as medicine, physics, or data tracking—you were looking for information on? 125031

It refers to a notable 2015 paper in Physical Review D titled "Self-similar inverse cascade of magnetic helicity driven by the chiral anomaly" (Phys. Rev. D 92, 125031 ). This research explores how magnetic fields behave in chiral plasmas, which is relevant to understanding the early universe. Recent supplemental applications (e

The number appears most prominently as a regulatory and scientific identifier, particularly within the medical and physical sciences. Pharmaceutical Identifier (BLA 125031) The number appears most prominently as a regulatory

The number also serves as a specific article identifier in high-level physics and engineering research: